Table 5.6g

Immunosuppression Use for Maintenance Between Discharge

and One Year Following Transplantation, 1995 to 2004

Recipients with Kidney Transplants

  Year of Transplant
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Transplants 11,081 11,397 11,701 12,451 12,758 13,611 14,265 14,778 15,136 16,004
Tx with Follow-up Immunosuppression Info 9,454 9,892 10,227 10,810 11,025 11,819 12,719 13,236 13,542 14,114
Corticosteroids Any in Category 99.6% 99.3% 98.9% 98.6% 98.5% 96.7% 95.6% 91.7% 86.0% 80.5%
Steroids 99.6% 99.3% 98.9% 98.6% 98.5% 96.7% 95.6% 91.7% 86.0% 80.5%
Cyclosporine Any in Category 89.3% 81.4% 74.8% 68.7% 63.7% 53.3% 39.5% 32.4% 26.9% 22.6%
Cyclosporin 49.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1%
Sandimmmune 20.7% 14.2% 9.2% 8.4% 8.5% 5.2% 3.3% 1.6% 1.2% 0.9%
Neoral 19.3% 67.2% 65.7% 60.3% 55.0% 45.9% 30.0% 23.4% 18.6% 15.2%
Gengraf 0.0% 0.0% 0.0% 0.0% 0.1% 2.2% 6.1% 7.2% 7.0% 6.3%
Eon 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.1%
Tacrolimus Any in Category 14.3% 22.1% 28.8% 36.8% 42.8% 52.7% 63.8% 69.2% 72.4% 76.3%
Tacrolimus 14.3% 22.1% 28.8% 36.8% 42.8% 52.7% 63.8% 69.2% 72.4% 76.3%
Antimetabolites Any in Category 74.6% 70.7% 88.4% 88.5% 89.4% 84.3% 83.6% 85.3% 85.3% 86.9%
Mycophenolate Mofetil 11.0% 39.9% 68.0% 74.8% 78.1% 76.5% 77.6% 80.5% 81.8% 82.4%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.2% 0.0% 0.0% 0.3% 0.5% 2.3%
Azathioprine 63.3% 30.6% 20.4% 13.5% 11.0% 7.6% 6.0% 4.4% 2.8% 1.8%
Leflunomide 0.0% 0.0% 0.0% 0.1% 0.0% 0.2% 0.0% 0.1% 0.2% 0.3%
Cytoxan 0.2% 0.2% 0.1% 0.0% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 0.3% 1.3% 2.4% 3.9% 5.9% 16.7% 21.6% 21.7% 21.0% 18.3%
Sirolimus 0.3% 1.3% 2.4% 3.4% 5.2% 16.5% 21.5% 21.1% 21.0% 18.1%
Everolimus 0.0% 0.0% 0.0% 0.5% 0.7% 0.1% 0.1% 0.6% 0.0% 0.2%


Source: OPTN/SRTR Data as of May 1, 2006.

Percentages are calculated based on the total number of patients with any immunosuppression use between discharge and one year following transplantation.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.